ethiodized oil emulsion 13

02/01/1984 - "EOE 13 infusion resulted in marked improvement in the demonstration of the neoplasm in all cases and allowed more accurate definition of tumor extent than was possible with standard scanning techniques. "
08/01/1984 - "EOE-13 is valuable for the detection of hepatic and splenic tumors."
02/01/1984 - "EOE 13 also proved to be of considerable value in assessment of therapeutic response in three patients, permitting more objective determination of tumor growth or regression. "
02/01/1984 - "In two cases EOE 13 enhancement was essential for complete radiographic depiction of tumor location, size, and extent. "
07/01/1984 - "High resolution CT scanning with EOE-13 allowed calculation of tumor doubling times, and therefore more precise management of cancer patients with metastases."

01/01/1987 - "Because EOE-13 is generally not available, these MR sequences should be the procedure of choice for the diagnosis of liver metastases."
11/01/1983 - "Detection of hepatic metastases: comparison of EOE-13 computed tomography and scintigraphy."
12/01/1982 - "Without exception, all the hepatic metastases were better delineated in the EOE 13 enhanced scans. "
12/01/1982 - "CT detection of hepatic metastases with Ethiodized Oil Emulsion 13."
10/01/1984 - "In each case, the diagnostic agent was administered through the infusion catheter at 0.66 ml/min. Hepatic perfusion patterns were identified with both imaging methods, but CT with EOE-13 yielded more precise anatomic detail and was unique in demonstrating the perfusion status of each hepatic metastasis. "

12/01/2009 - "Seventeen patients with EoE, 13 with GERD, and 11 controls were studied. "
06/01/2014 - "ALOX15 was positive in 90.5% of patients with EoE (13/16 in group 1, 4/4 in group 2, 31/33 in group 3) versus 44% of patients with GERD (4/8 in group 1, 0/1 in group 2, and 0/0 in group 3), 2 of 9 (22%) of patients with 6 to 15 eos/HPF, and was negative in all patients with GERD with biopsies containing 5 eos/HPF or less, all patients with candida esophagitis, and all normal controls. "
01/01/2022 - "3,976 adult patients with confirmed esophageal disease were included: 30% with achalasia or EGJOO, 13% with EoE, 13% with GERD, 39% normal motility. "

02/01/1984 - "Ethiodized oil emulsion 13 in computed tomography of hepatoma."
10/01/1983 - "Poor detection of a hepatoma with a hepatic specific contrast agent (EOE 13)."
02/01/1984 - "Six patients with biopsy-proven hepatoma were prospectively evaluated both by conventional computed tomography (CT) and by scans using ethiodized oil emulsion 13 (EOE 13) as a contrast agent. "

01/01/1985 - "CT evaluation of hepatic and splenic trauma with EOE-13. "